New vaccine for hepatitis C virus
Murdoch University researchers have begun a study to develop a new and innovative vaccine for the hepatitis C virus (HCV).
HCV is spread through blood-to-blood contact and causes liver inflammation and liver disease. It affects about 284,000 Australians and 212,000 are living with chronic HCV.
The research in collaboration with Oxford University and funded by the McCusker Foundation, is using a new approach to develop the vaccine, which aims to protect against the majority of circulating HCV strains.
Researcher Michaela Lucas said: Previous attempts to create a vaccine have been limited because like HIV, hepatitis C virus escapes our immune system by rapid change of its genome and shape.
Our project is using genetics to identify these escape patterns so we can create vaccines that take this ability of the virus to change into account. That should mean a higher chance of success.
Dr. Lucas said if successful, the vaccine could halt the infection cycle by protecting people at risk from initial infection and re-infection.
Hepatitis C virus infection is a major global health problem and despite public health efforts in Australia to prevent HCV infection, it has become the most common bloodborne infection, she said.
There is currently no vaccine for the prevention of HCV and previous HCV infection does generally not protect from re-infection. Furthermore, available treatment is not accessible to all, is expensive and can have life-threatening complications.
Even if treatment and newer treatment strategies are successful and eradicate the virus within an individual, it will not prevent re-infection, which is common in high-risk exposure groups. A vaccine against HCV would provide a mechanism to stop the continuation of the infection cycle.
Provided by Murdoch University
-
Early treatment is key to combating hepatitis C virus
Aug 08, 2008 |
not rated yet |
0
-
Possible hepatitis C vaccine
Sep 05, 2007 |
not rated yet |
0
-
Improved culture system for hepatitis C virus infection
Jul 16, 2008 |
not rated yet |
0
-
Scientists Model Hepatitis C Virus
May 25, 2007 |
not rated yet |
0
-
The risk factors of idiopathic pulmonary fibrosis in HCV patients
Oct 23, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Acne pill benefits outweigh blood clot risk: EU agency
Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins—when correctly prescribed.
Medications
May 17, 2013 |
not rated yet |
0
First influenza vaccine brought to clinical testing
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...
Medications
May 17, 2013 |
5 / 5 (1) |
0
Aspirin not always best treatment for many individuals
(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...
Medications
May 16, 2013 |
3.5 / 5 (2) |
0
|
FDA: lower ambien's dose to prevent drowsy driving
(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...
Medications
May 15, 2013 |
not rated yet |
0
Simponi approved for ulcerative colitis
(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.
Medications
May 15, 2013 |
not rated yet |
0
Researchers identify a potential new risk for sleep apnea: Asthma
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Ginger compounds may be effective in treating asthma symptoms
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...